Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE In particular, both homozygous AA and heterozygous CA genotypes of rs16901979, as well as the AA and CA genotypes of rs1447295, were associated with the risk of prostate cancer. 30061842

2018

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE There are strong association between rs1447295 polymorphism and prostate cancer susceptibility in different ethnic groups and different prostate cancer stage, suggesting that rs1447295 might serve as a reliable biomarker for prostate cancer diagnosis. 28978014

2017

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE Therefore, this meta-analysis demonstrated that 8q24 polymorphisms (rs6983267 T>G, rs1447295 C>A, rs16901979 C>A, rs6983561 A>C and rs10090154 C>T) were associated with the susceptibility to PCa, which held the potential biomarkers for PCa risk. 29158792

2017

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE Therefore, this meta-analysis demonstrated that 8q24 polymorphisms (rs6983267 T>G, rs1447295 C>A, rs16901979 C>A, rs6983561 A>C and rs10090154 C>T) were associated with the susceptibility to PCa, which held the potential biomarkers for PCa risk. 29158792

2017

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE The cumulative effects test of risk alleles (rs rs1983891, rs339331, rs16901966, rs1447295 and rs10090154) showed an increasing risk to PCa in a frequency-dependent manner (ptrend=0.001), and men with more than 3 risk alleles had the most significant susceptibility to PCa (OR=1.99, p=0.001), compared with those who had one risk allele (OR=1.17, p=0.486). 26537068

2016

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE Overall, though no association was observed between the rs</span>6983267 polymorphism and risk of prostate cancer, subgroup analysis according to ethnicity showed a significant association between the rs6983267 polymorphism and risk of prostate cancer among white European men [recessive model: GG vs TG + TT, OR=1.21, (95% CI: 1.03, 1.42), P=0.02]. 27009866

2016

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE Interestingly, the effect of rs1447295 on PCa risk was observed among Caucasians and Asians, but not Africa-Americans. 26159557

2015

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE Three 8q24 polymorphisms (rs1447295 C>A, rs16901979 C>A, and rs6983267 T>G) have been extensively investigated for their association with prostate cancer (PCa) susceptibility, yet conclusions are contradictory. 26159557

2015

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE Similarly, in a subgroup analysis of European and Asian descent, our results revealed that there are associations between rs6983267 T/G polymorphism and PCa susceptibility with the dominant model (GG vs GT+TT), recessive model (GG+GT vs TT), and homozygote comparison (GG vs TT). 26782586

2015

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE The evidence for 8q24 SNPs with PCa risk in northern Chinese men showed rs16901966, rs1447295 and rs10090154 at 8q24 (region 1, region 2) to be strongly associated with PCa and clinical covariates. 24377597

2014

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE We showed statistically significant association of the A allele of rs1447295 (OR [CI 95%] = 1.96 [1.37-2.81], P<0.0001) and the T allele of rs10090154 (OR [CI 95%] = 2.14 [1.41-3.26], P<0.0001) with CaP. 23628314

2014

dbSNP: rs1447295
rs1447295
A 0.800 GeneticVariation GWASDB Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544

2014

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01). 25315430

2014

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE The polymorphism rs6983267 from region 3 of the chromosome 8q24 appears to be a prominent risk factor for PCa and a biomarker for cancer aggressiveness in the group of patients who presented higher levels of PSA at the time of diagnosis. 24224612

2014

dbSNP: rs6983267
rs6983267
G 0.800 GeneticVariation GWASDB Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544

2014

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation GWASDB Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. 23555315

2013

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation GWASDB Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. 23555315

2013

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE Significant associations were observed for rs4430796 TT with Gleason scores of ≥ 7 (OR = 1.76, 95% CI = 1.14-2.73) and prostate-specific antigen (PSA) levels of ≥ 10 ng/ml at diagnosis (OR = 1.63, 95% CI = 1.01-2.63), as well as for rs6983267 GG with stage 3-4 CaPs (OR = 1.91, 95% CI = 1.01-3.61). 22561070

2013

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation GWASDB Evaluating genetic risk for prostate cancer among Japanese and Latinos. 22923026

2012

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE • The frequencies of three CaP risk alleles (rs1447295 [8q24], P= 0.004; rs1571801 [9q33.2], P= 0.03; rs11228565 [11q13], P= 0.02) were significantly higher in men with 'unfavourable' pathological characteristics. 22077888

2012

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE For northern Chinese men rs16901966, rs1447295, rs11986220 and rs10090154 at 8q24 (region 1, region 2) are associated with prostate cancer and prostate cancer related clinical covariates. 22099997

2012

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE The A allele at SNP rs1447295 was associated with the incidence of prostate cancer. 22583965

2012

dbSNP: rs6983267
rs6983267
0.800 GeneticVariation BEFREE The results of the meta-analyses indicate that rs6983267, rs1447295, rs6983561, rs7837688, rs16901979, and DG8S737 are significantly associated with a higher risk for PCa for at least one race, whereas the variants rs13254738 and rs7000448 are not. 22382457

2012

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE Allele -8 of microsatellite DG8S737 with 22 repeats and allele A of the single-nucleotide polymorphism (SNP) rs1447295 have been found to be significantly associated with prostate cancer. 20700145

2011

dbSNP: rs1447295
rs1447295
0.800 GeneticVariation BEFREE There was a tendency towards significantly increased risk for SNPs rs1447295 and rs6983267 in men with early-onset prostate cancer. 21557270

2011